1. 新勱德自研產品 This product is independently designed and developed by Singmed.
2. 單劑量膠囊型DPI Single Dose Capsule DPI
3. 新勱德設計與制造的裝置已與中國多家頭部上市制藥企業(yè)開展生物等效性研究（采用諾華的三種藥），已實現(xiàn)與原研裝置的可替換。The self-developed Breezhaler® designed and manufactured by Singmed has been conducting Bioequivalence Researching (loaded with Indacaterol/Glycopyrronium Bromide/Indacaterol Maleate and Glycopyrronium Bromide produced by NOVARTIS) with a number of Chinese leading listed pharmaceutical companies, and has realized the replacement of the novel device.
4. 新勱德仿制裝置規(guī)避了原研的專利限制，在保持與原研產品相同空氣動力學機理的情況下，形成了新的設計和專利。
The generic device developed by Singmed circumvents the patent restrictions of the novel product, incorporating an innovating design and gaining our own patent while maintaining the same aerodynamic mechanism as the original product.
2006-2025 上海博華國際展覽有限公司版權所有（保留一切權利）
滬ICP備05034851號-57
